XML 32 R20.htm IDEA: XBRL DOCUMENT
v3.25.4

Net Income Per Common Share | 12 Months Ended
--- | ---
Dec. 31, 2025
Earnings Per Share [Abstract] |
Net Income Per Common Share | Note 11 - Net Income Per Common Share The following table displays a reconciliation of the information used in calculating basic and diluted net income per common share for the years ended December 31, 2025, 2024, and 2023.
| Years Ended December 31,
(in thousands, except per share data) | 2025 |  | 2024 |  | 2023
Basic Net Income Per Common Share: |  |  |  |  |
Net income available to common shareholders | $ | 746,655 |  |  | $ | 439,557 |  |  | $ | 507,755 |
Weighted average common shares outstanding | 139,296 |  |  | 144,164 |  |  | 146,115 |
Net income per common share, basic | $ | 5.36 |  |  | $ | 3.05 |  |  | $ | 3.48 |
Diluted Net Income Per Common Share: |  |  |  |  |
Net income available to common shareholders | $ | 746,655 |  |  | $ | 439,557 |  |  | $ | 507,755 |
Weighted average common shares outstanding | 139,296 |  |  | 144,164 |  |  | 146,115 |
Effect of dilutive outstanding equity-based awards | 853 |  |  | 834 |  |  | 619 |
Weighted average diluted common shares | 140,149 |  |  | 144,998 |  |  | 146,734 |
Net income per common share, diluted | $ | 5.33 |  |  | $ | 3.03 |  |  | $ | 3.46 |
Diluted net income per common share incorporates the potential impact of contingently issuable shares, such as those related to outstanding stock options, restricted share units (RSUs), and performance share units (PSUs), including awards which require future service and meeting certain performance and market metrics as a condition of delivery of the underlying common stock. During periods where the effect of these instruments is antidilutive, meaning their inclusion would increase earnings per share, they are excluded from the calculation. For the years ended December 31, 2025, 2024 and 2023, there were approximately 83 thousand, 2 thousand and 877 thousand shares, respectively, related to RSUs and PSUs that were excluded from the diluted EPS calculation because they were antidilutive. These shares primarily relate to unvested PSUs where the performance conditions were not met or not probable of being met. There were no shares excluded for the same periods related to stock options that would have been antidilutive. For the year ended December 31, 2025, there were no shares, and for the years ended December 31, 2024 and 2023, approximately 20 thousand and 272 thousand shares, respectively, were excluded from the diluted EPS calculation related to stock options as they would have been antidilutive, due to the exercise prices exceeding the average market price. For the same periods, there were no shares excluded related to RSUs and PSUs that would have been antidilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration